Skip to main content
. 2019 Aug 7;146(8):2201–2208. doi: 10.1002/ijc.32584

Table 1.

Preprogram characteristics of municipalities by date of entry to the screening program1

Date of program entry Number of municipalities (N = 138) Female population, 1989–19942 Percentage of females aged 50–69, 1989–19943 Breast cancer incidence, 1989–19944 Five‐year breast cancer prevalence, January 19945 Percentage of females aged 50–69 screened at first invitation6
January to June 1995 33 11,045 ± 16,349 19 ± 2 112 ± 23 419 ± 104 81 ± 5
July to December 1995 34 10,887 ± 10,785 19 ± 3 117 ± 25 438 ± 100 81 ± 3
January to June 1996 33 12,968 ± 13,851 19 ± 2 120 ± 37 487 ± 111 81 ± 4
July to December 1996 19 13,721 ± 17,217 20 ± 3 130 ± 29 480 ± 87 80 ± 6
January to June 1997 12 10,175 ± 10,574 19 ± 3 113 ± 43 460 ± 164 82 ± 5
July to December 1997 7 8,044 ± 4,601 19 ± 4 102 ± 29 373 ± 115 79 ± 6
p value7 0.95 0.47 0.31 0.03 0.89
All municipalities 138 11,606 ± 13,645 19.0 ± 2.0 117 ± 30 449 ± 111 81 ± 5
1

Plus–minus values are means ± SD. Only municipalities that started organized screening between January 1995 and December 1997.

2

The number of females in a municipality averaged over the period 1989–1994.

3

Percentage of the female population in a municipality who is aged 50–69 and so eligible for screening, averaged over the period 1989–1994.

4

Municipality‐specific median over the period 1989–1994 of the annual number of newly diagnosed breast cancer cases per 100,000 female inhabitants.

5

The number of cancer patients who were diagnosed with breast cancer in the 5 years preceding January 1994 and still alive at that time per 100,000 female inhabitants of a municipality.

6

Data available for only 133 municipalities.

7

p values are for the Kruskal‐Wallis test of no difference by date of program entry.